TL;DR: Travel insurance after a blood clot or DVT requires full disclosure of the event, its date, any underlying clotting disorder, and current anticoagulant treatment. A recent DVT or pulmonary embolism significantly affects underwriting - many insurers apply waiting periods before offering cover. Specialist brokers via MoneyHelper's directory handle complex clot histories where standard insurers decline.
KEY FACTS
|
What you must declare after a blood clot or DVT
Following a DVT or pulmonary embolism (PE), you are required to declare the event on any travel insurance application. The declaration should include the date of the clot, whether it was a DVT, PE, or both, the cause or trigger if identified - including whether it was provoked by surgery, immobility, pregnancy, or cancer, or unprovoked - and all current anticoagulant medications including direct oral anticoagulants (DOACs) such as rivaroxaban or apixaban, or warfarin. If a thrombophilia has been diagnosed - such as Factor V Leiden, prothrombin gene mutation, antiphospholipid syndrome, or protein C or S deficiency - this must be declared as a separate pre-existing condition. Any prior DVT or PE episodes must also be declared, as recurrence history is a key underwriting factor. If your clot was associated with a malignancy, the cancer itself requires separate disclosure. The Consumer Insurance (Disclosure and Representations) Act 2012 requires accurate disclosure of all material facts at the point of application.
How insurers assess DVT and clot history
The recency of the clot event is the single most influential underwriting factor. A DVT or PE within the past three months is typically treated by most insurers as an acute event, with cover either declined or subject to a waiting period before standard terms apply. Beyond three months, underwriting depends on whether treatment is complete or ongoing, whether anticoagulation is temporary or indefinite, and whether the cause was provoked or unprovoked. A provoked DVT following surgery with a completed short course of anticoagulants and no underlying thrombophilia represents a lower ongoing risk than an unprovoked PE in a patient on indefinite anticoagulation with an identified hereditary clotting disorder. Standard insurers frequently refer clot histories to specialist underwriters. MoneyHelper's directory (moneyhelper.org.uk/en/everyday-money/insurance/travel-insurance-directory) is the primary route to identifying brokers with appropriate thrombosis underwriting experience.
Flying after a DVT - risk factors and insurance implications
Long-haul flights are an established risk factor for DVT recurrence in patients with prior clot history. The NHS advises passengers at elevated DVT risk to wear correctly fitted below-knee compression stockings rated at 15 to 30 mmHg on flights over four hours, to stay hydrated, and to perform regular lower-leg exercises during the flight (NHS.uk). Before booking any long-haul travel following a DVT or PE, discuss flight suitability with your GP or haematologist. Most insurers require that travel is not against medical advice as a condition of any pre-existing condition claim - if your clinician advises against long-haul flying and you travel anyway, a clot-related claim may be declined even where the condition is declared and accepted. Carry a copy of your most recent clinical letter confirming fitness to travel, your anticoagulant prescription, and information about your anticoagulation management plan while abroad.
Anticoagulant management during international travel
Travel across time zones with anticoagulant therapy requires advance planning. For warfarin users, INR monitoring may be required during extended travel and arrangements for testing abroad should be confirmed before departure. DOAC users taking rivaroxaban or apixaban on twice-daily dosing need a clear plan for adjusting timing when crossing significant time zones. Discuss this with your anticoagulation clinic or GP before travel. Carry sufficient anticoagulant medication in hand luggage for the full trip plus a contingency supply - anticoagulants such as warfarin are not universally available in identical formulations internationally, and DOACs may not be available locally in some destinations. Carry your anticoagulant alert card, issued in the UK by anticoagulation clinics and NHS trusts, which specifies your medication, indication, and dose and is useful in any emergency medical context abroad.
What a post-clot travel insurance policy should cover
A policy that accepts a clot history as a declared condition should cover emergency medical treatment abroad for DVT or PE recurrence, including hospitalisation, anticoagulation therapy, and intensive care if required. It should cover medical repatriation if a clot event requires return to the UK under medical supervision, and trip cancellation or curtailment if a clot event before or during travel renders you medically unfit to travel, confirmed by a clinician. Check whether the policy applies any exclusion for DVT or clot events arising during long-haul flights specifically - some policies include wording limiting claims where a recurrence occurs during conditions known to elevate DVT risk. Confirm whether the policy covers ongoing anticoagulant costs if treatment needs to be adjusted or extended during travel, and whether INR monitoring costs for warfarin users are covered.
| Editorial Disclaimer: Kaeltripton.com is an independent editorial publisher and is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Always verify rates and product details with the relevant provider, the FCA register, HMRC or the Bank of England before any financial decision. |
Frequently Asked Questions
How soon after a DVT can I get travel insurance?
Most insurers apply a waiting period following an acute DVT or PE before standard cover terms apply. This varies by insurer - commonly three to six months from the date of the clot event. During any waiting period, specialist brokers may still be able to offer cover, though premiums and exclusions will reflect the elevated recurrence risk. Use MoneyHelper's directory to identify relevant brokers.
Do I need to declare a DVT that happened several years ago?
Yes. A prior DVT or PE is a pre-existing condition regardless of how long ago it occurred, particularly if it resulted in an identified thrombophilia, ongoing anticoagulation, or if you are still under clinical review. Disclose all prior clot events and let the insurer determine their underwriting relevance.
Does having a hereditary clotting disorder affect my travel insurance significantly?
A diagnosed thrombophilia such as Factor V Leiden or antiphospholipid syndrome represents an ongoing recurrence risk and must be declared as a separate condition alongside any prior clot events. It typically results in higher premiums and may limit the geographic cover available from some specialist insurers. Full disclosure at the quotation stage is essential.
What should I do if I suspect a DVT or PE while abroad?
Seek emergency medical attention immediately and call local emergency services. DVT and PE are medical emergencies. Once stabilised, contact your travel insurer's 24-hour emergency assistance line. A policy covering your clot history should coordinate ongoing care and arrange repatriation if required.
Does the GHIC cover DVT treatment in Europe?
The GHIC entitles UK residents to emergency state treatment for DVT or PE in EU countries at the same cost as local residents. It does not cover repatriation, private facilities, or cancellation costs. The NHS Business Services Authority confirms it is not a substitute for travel insurance (nhsbsa.nhs.uk).
How We Verified This Guide
This guide was researched against primary UK sources including NHS.uk clinical guidance on deep vein thrombosis and pulmonary embolism, FCA Policy Statement PS22/9 (Consumer Duty), the Consumer Insurance (Disclosure and Representations) Act 2012 via legislation.gov.uk, FCDO foreign travel advice, MoneyHelper's travel insurance directory, and NHS Business Services Authority GHIC guidance. Last reviewed May 2026 by Chandraketu Tripathi, finance editor at Kaeltripton.
